stockrowHUTCHMED (China) Limited Sponsored ADR
HCM Healthcare Drug Manufacturers Specialty & Generic
HUTCHMED (China) Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $548.5 million, down 13.0% from fiscal 2024.
Follow HCM
Alert me
HUTCHMED (China) Limited Sponsored ADR (HCM) Book value per share
HUTCHMED (China) Limited Sponsored ADR's book value per share at the end of fiscal 2025 was 7.3×, up 61.6% from 4.5× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 0.0×. Over the past ten years it has ranged from 0.9× (fiscal 2015) to 7.3× (fiscal 2025) — the current reading is the highest in ten years. HUTCHMED (China) Limited Sponsored ADR ranks 58th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 7.3× | 61.56% |
| FY2024 | 4.5× | 3.14% |
| FY2023 | 4.4× | 16.38% |
| FY2022 | 3.8× | (42.67%) |
| FY2021 | 6.6× | 76.37% |
| FY2020 | 3.7× | 58.19% |
| FY2019 | 2.4× | (24.26%) |
| FY2018 | 3.1× | (21.02%) |
| FY2017 | 3.9× | 129.95% |
| FY2016 | 1.7× | 82.62% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Jun 2025 | 0.0× | — |
| Dec 2024 | 0.0× | — |
| 21 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| PBH Prestige Consumer Healthcare Inc. compare | 40.9× |
| ANIP ANI Pharmaceuticals, Inc. compare | 30.0× |
| PRGO Perrigo Company plc compare | 17.5× |
| TRLV Trulieve Cannabis Corp. compare | 4.0× |
| XERS Xeris Biopharma Holdings, Inc. compare | 0.3× |
| HCM HUTCHMED (China) Limited Sponsored ADR | 0.0× |
| RGC Regencell Bioscience Holdings Limited compare | 0.0× |
| ALVO Alvotech compare | 0.0× |
| BCRX BioCryst Pharmaceuticals, Inc. compare | −1.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on HCM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement